Genotoxicity Testing
At Vivotecnia we perform the Ames Test (OECD TG 471) as part of our standardized battery of genotoxicity studies, key for the preclinical evaluation of new compounds in regulated industries. This in vitro test allows detecting the mutagenic capacity of chemical substances through the use of modified strains of Salmonella typhimurium and Escherichia coli.
Preclinical regulatory CRO
Established – 2000
The Ames Test is mandatory for the approval of drugs, industrial chemicals, cosmetic ingredients and food additives. Its inclusion in the registration dossier is required by agencies such as the EMA, FDA and OECD, and is part of the ICH S2(R1) guidelines for drug development.
Chemical
Cosmetics
Vivotecnia has a highly specialized bioanalytical unit that combines state-of-the-art technology with a multidisciplinary team of experts in regulated preclinical studies.
Provantis® platform for document control, traceability and regulatory compliance.
All assays are performed under GLP certification and are audited by our internal Quality Assurance unit.
Do you need to perform an Ames Test as
part of your regulatory dossier?
